175 related articles for article (PubMed ID: 6970814)
1. Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis.
Lom-Orta H; Alarcon-Segovia D; Diaz-Jouanen E
J Rheumatol; 1980; 7(6):831-7. PubMed ID: 6970814
[TBL] [Abstract][Full Text] [Related]
2. Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE?
Al Attia HM
Int J Dermatol; 2006 Apr; 45(4):366-9. PubMed ID: 16650159
[TBL] [Abstract][Full Text] [Related]
3. Incomplete lupus erythematosus.
Greer JM; Panush RS
Arch Intern Med; 1989 Nov; 149(11):2473-6. PubMed ID: 2818107
[TBL] [Abstract][Full Text] [Related]
4. Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus.
Costenbader KH; Karlson EW; Mandl LA
J Rheumatol; 2002 Dec; 29(12):2545-50. PubMed ID: 12465149
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunological manifestations of systemic lupus erythematosus: study on 146 south Tunisian patients.
Jallouli M; Frigui M; Hmida MB; Marzouk S; Kaddour N; Bahloul Z
Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):1001-8. PubMed ID: 18974596
[TBL] [Abstract][Full Text] [Related]
6. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
[TBL] [Abstract][Full Text] [Related]
7. Isolated antinuclear antibody-negative lupus nephropathy in young children.
Enriquez JL; Rajaraman S; Kalia A; Brouhard BH; Travis LB
Child Nephrol Urol; 1988-1989; 9(6):340-6. PubMed ID: 3272856
[TBL] [Abstract][Full Text] [Related]
8. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
9. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
[TBL] [Abstract][Full Text] [Related]
10. [Seronegative leukocytoclastic vasculitis preceding the onset of disseminated systemic lupus erythematosus].
Chevalier X; Belmatoug N; Kahn MF
Rev Rhum Mal Osteoartic; 1990 Nov; 57(11):779-83. PubMed ID: 2291068
[TBL] [Abstract][Full Text] [Related]
11. Lupus nephropathy as the initial manifestation of systemic lupus erythematosus.
Lynn RI; Siegel NJ; Hayslett JP
Yale J Biol Med; 1980; 53(5):353-9. PubMed ID: 6971530
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of lupus erythematosus].
Gschnait F; Brenner W; Holubar K
Hautarzt; 1979 Dec; 30(12):646-50. PubMed ID: 317653
[TBL] [Abstract][Full Text] [Related]
13. Abnormal laboratory test results and their relationship to prognosis in discoid lupus erythematosus. A long-term follow-up study of 92 patients.
Millard LG; Rowell NR
Arch Dermatol; 1979 Sep; 115(9):1055-8. PubMed ID: 314780
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
15. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
16. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
Ferluga D; Jerse M; Vizjak A; Hvala A; Rozman B; Kos-Golja M; Bren AF
Wien Klin Wochenschr; 2000 Aug; 112(15-16):692-701. PubMed ID: 11020959
[TBL] [Abstract][Full Text] [Related]
17. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
18. Adult celiac disease followed by onset of systemic lupus erythematosus.
Freeman HJ
J Clin Gastroenterol; 2008 Mar; 42(3):252-5. PubMed ID: 18223501
[TBL] [Abstract][Full Text] [Related]
19. [Classification and immunosuppressive therapy of systemic lupus erythematosus: long-term follow-up of 31 patients (author's transl)].
Fischer M; Mitrou PS; Mitrou G; Spernau S
Dtsch Med Wochenschr; 1975 Dec; 100(51):2591-8. PubMed ID: 1201730
[TBL] [Abstract][Full Text] [Related]
20. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]